Senior Management

Tom Baird

Chief Executive Officer and Director

Tom is a seasoned CEO and strategy executive who has led a number of small and medium sized businesses to turnaround and exits. He has also led corporate development and product management organizations for both publicly traded and private companies such as TRW Inc. (now Northrop Grumman), Reynolds and Reynolds and Mitchell International. Most recently, Tom was a co-founding partner of a licensed California cannabis manufacturer. He is a hands-on operational executive that drives results.

Brian Zasitko

Chief Financial Officer

Brian has over 13 years of experience across a variety of private and public sector companies in the cannabis, agriculture, manufacturing, and utility industries. He has extensive experience in financial reporting and corporate governance, as well as in the capital markets. Previously, Mr. Zasitko was a manager at Ernst & Young LLP, where he obtained his CPA, CA designation.

Maghsoud Dariani

Chief Science Officer

Dr. Dariani has years of expertise with life sciences companies. He is currently President and CEO of Semorex Inc., a privately held company focused on the discovery and development of novel therapeutics for cancer. Prior to joining Semorex, Mr. Dariani was President of Focus Pharmaceuticals, Inc., where he managed the development and approval of drug products, achieving an FDA approval and bringing another to the clinical evaluation stage. He subsequently negotiated the successful sale of the company in February 2003. Prior to Focus, Mr. Dariani was Vice President of the chiral pharmaceutical business unit at Celgene Corporation. During his twelve years at Celgene, Mr. Dariani was responsible for the successful development and FDA approval of the chirally pure versions of Ritalin, which are currently marketed by Novartis under the Focalin and Focalin XR trade names.